The EuroSIDA study: 25 years of scientific achievements
The EuroSIDA study was initiated in 1994 and follows adult people living with HIV (PLHIV) in 100 collaborating clinics across 35 countries covering all European regions, Israel and Argentina. The study aims to study the long‐term virological, immunological and clinical outcomes of PLHIV and to monit...
Gespeichert in:
| Veröffentlicht in: | HIV medicine 2020-02, Vol.21 (2), p.71-83 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 83 |
|---|---|
| container_issue | 2 |
| container_start_page | 71 |
| container_title | HIV medicine |
| container_volume | 21 |
| creator | Laut, K Kirk, O Rockstroh, J Phillips, A Ledergerber, B Gatell, J Gazzard, B Horban, A Karpov, I Losso, M d’Arminio Monforte, A Pedersen, C Ristola, M Reiss, P Scherrer, AU Wit, S Aho, I Rasmussen, LD Svedhem, V Wandeler, G Pradier, C Chkhartishvili, N Matulionyte, R Oprea, C Kowalska, JD Begovac, J Miró, JM Guaraldi, G Paredes, R Raben, D Podlekareva, D Peters, L Lundgren, JD Mocroft, A |
| description | The EuroSIDA study was initiated in 1994 and follows adult people living with HIV (PLHIV) in 100 collaborating clinics across 35 countries covering all European regions, Israel and Argentina. The study aims to study the long‐term virological, immunological and clinical outcomes of PLHIV and to monitor temporal changes and regional differences in outcomes across Europe. Annually collected data include basic demographic characteristics, information on AIDS‐ and non‐AIDS‐related clinical events, and details about antiretroviral therapy (ART), hepatitis C treatment and other medications, in addition to a range of laboratory values. The summer 2016 data set held data from a total of 23 071 individuals contributing 174 481 person‐years of follow‐up, while EuroSIDA’s unique plasma repository held over 160 000 samples. Over the past 25 years, close to 300 articles have been published in peer‐reviewed journals (h‐index 52), covering a range of scientific focus areas, including monitoring of clinical and virological outcomes, ART uptake, efficacy and adverse events, the influence of hepatitis virus coinfection, variation in the quality of HIV care and management across settings and regions, and biomarker research. Recognizing that there remain unresolved issues in the clinical care and management of PLHIV in Europe, EuroSIDA was one of the cohorts to found The International Cohort Consortium of Infectious Disease (RESPOND) cohort consortium on infectious diseases in 2017. In celebration of the EuroSIDA study’s 25th anniversary, this article aims to summarize key scientific findings and outline current and future scientific focus areas. |
| doi_str_mv | 10.1111/hiv.12810 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_476179</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2341998603</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4260-72e8fc26406cfc9c816e8655b72be4dbcea539e5d5f5b067613331859bfff1843</originalsourceid><addsrcrecordid>eNp10E1PwjAcBvDGaATRg1_ALPGih0nf13kjiEJC4kH02mzl31AEhiuD7NtbGXIwsZe-5Ncn7YPQNcEPJIzuzG0fCFUEn6A24VLFhKbsdL_mMZWSttCF93OMScJSfI5ajEieEJW0UTKZQTSoyuJt9NSL_Kaa1o8RFVENWemjwkbeOFhtnHUmyszMwRaWYe8v0ZnNFh6uDnMHvT8PJv1hPH59GfV749hwKnGcUFDWUMmxNNakRhEJSgqRJzQHPs0NZIKlIKbCihzLRBLGGFEiza21RHHWQXGT63ewrnK9Lt0yK2tdZE4fjj7DCjQPd5M0-LvGr8viqwK_0UvnDSwW2QqKymvKsBKUSIYDvf1D50VVrsJvguIkTZXELKj7Rpmy8L4Ee3wCwfqnfR3a1_v2g705JFb5EqZH-Vt3AN0G7NwC6v-T9HD00UR-Azqoi9c</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2341998603</pqid></control><display><type>article</type><title>The EuroSIDA study: 25 years of scientific achievements</title><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Free Content</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>SWEPUB Freely available online</source><creator>Laut, K ; Kirk, O ; Rockstroh, J ; Phillips, A ; Ledergerber, B ; Gatell, J ; Gazzard, B ; Horban, A ; Karpov, I ; Losso, M ; d’Arminio Monforte, A ; Pedersen, C ; Ristola, M ; Reiss, P ; Scherrer, AU ; Wit, S ; Aho, I ; Rasmussen, LD ; Svedhem, V ; Wandeler, G ; Pradier, C ; Chkhartishvili, N ; Matulionyte, R ; Oprea, C ; Kowalska, JD ; Begovac, J ; Miró, JM ; Guaraldi, G ; Paredes, R ; Raben, D ; Podlekareva, D ; Peters, L ; Lundgren, JD ; Mocroft, A</creator><creatorcontrib>Laut, K ; Kirk, O ; Rockstroh, J ; Phillips, A ; Ledergerber, B ; Gatell, J ; Gazzard, B ; Horban, A ; Karpov, I ; Losso, M ; d’Arminio Monforte, A ; Pedersen, C ; Ristola, M ; Reiss, P ; Scherrer, AU ; Wit, S ; Aho, I ; Rasmussen, LD ; Svedhem, V ; Wandeler, G ; Pradier, C ; Chkhartishvili, N ; Matulionyte, R ; Oprea, C ; Kowalska, JD ; Begovac, J ; Miró, JM ; Guaraldi, G ; Paredes, R ; Raben, D ; Podlekareva, D ; Peters, L ; Lundgren, JD ; Mocroft, A</creatorcontrib><description>The EuroSIDA study was initiated in 1994 and follows adult people living with HIV (PLHIV) in 100 collaborating clinics across 35 countries covering all European regions, Israel and Argentina. The study aims to study the long‐term virological, immunological and clinical outcomes of PLHIV and to monitor temporal changes and regional differences in outcomes across Europe. Annually collected data include basic demographic characteristics, information on AIDS‐ and non‐AIDS‐related clinical events, and details about antiretroviral therapy (ART), hepatitis C treatment and other medications, in addition to a range of laboratory values. The summer 2016 data set held data from a total of 23 071 individuals contributing 174 481 person‐years of follow‐up, while EuroSIDA’s unique plasma repository held over 160 000 samples. Over the past 25 years, close to 300 articles have been published in peer‐reviewed journals (h‐index 52), covering a range of scientific focus areas, including monitoring of clinical and virological outcomes, ART uptake, efficacy and adverse events, the influence of hepatitis virus coinfection, variation in the quality of HIV care and management across settings and regions, and biomarker research. Recognizing that there remain unresolved issues in the clinical care and management of PLHIV in Europe, EuroSIDA was one of the cohorts to found The International Cohort Consortium of Infectious Disease (RESPOND) cohort consortium on infectious diseases in 2017. In celebration of the EuroSIDA study’s 25th anniversary, this article aims to summarize key scientific findings and outline current and future scientific focus areas.</description><identifier>ISSN: 1464-2662</identifier><identifier>EISSN: 1468-1293</identifier><identifier>DOI: 10.1111/hiv.12810</identifier><identifier>PMID: 31647187</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Acquired immune deficiency syndrome ; AIDS ; Antiretroviral agents ; Antiretroviral therapy ; Biomarkers ; Cohort analysis ; cohort studies ; Consortia ; Data collection ; Demographics ; Europe ; Hepatitis ; Hepatitis C ; HIV ; Human immunodeficiency virus ; Immunology ; Infectious diseases ; surveillance ; Viruses</subject><ispartof>HIV medicine, 2020-02, Vol.21 (2), p.71-83</ispartof><rights>2019 British HIV Association</rights><rights>2019 British HIV Association.</rights><rights>HIV Medicine © 2020 British HIV Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4260-72e8fc26406cfc9c816e8655b72be4dbcea539e5d5f5b067613331859bfff1843</citedby><cites>FETCH-LOGICAL-c4260-72e8fc26406cfc9c816e8655b72be4dbcea539e5d5f5b067613331859bfff1843</cites><orcidid>0000-0003-1166-4462 ; 0000-0002-5724-3914 ; 0000-0001-7056-570X ; 0000-0003-2384-4807 ; 0000-0003-0073-1789 ; 0000-0001-8316-1122</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fhiv.12810$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fhiv.12810$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,550,776,780,881,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31647187$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:142152947$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Laut, K</creatorcontrib><creatorcontrib>Kirk, O</creatorcontrib><creatorcontrib>Rockstroh, J</creatorcontrib><creatorcontrib>Phillips, A</creatorcontrib><creatorcontrib>Ledergerber, B</creatorcontrib><creatorcontrib>Gatell, J</creatorcontrib><creatorcontrib>Gazzard, B</creatorcontrib><creatorcontrib>Horban, A</creatorcontrib><creatorcontrib>Karpov, I</creatorcontrib><creatorcontrib>Losso, M</creatorcontrib><creatorcontrib>d’Arminio Monforte, A</creatorcontrib><creatorcontrib>Pedersen, C</creatorcontrib><creatorcontrib>Ristola, M</creatorcontrib><creatorcontrib>Reiss, P</creatorcontrib><creatorcontrib>Scherrer, AU</creatorcontrib><creatorcontrib>Wit, S</creatorcontrib><creatorcontrib>Aho, I</creatorcontrib><creatorcontrib>Rasmussen, LD</creatorcontrib><creatorcontrib>Svedhem, V</creatorcontrib><creatorcontrib>Wandeler, G</creatorcontrib><creatorcontrib>Pradier, C</creatorcontrib><creatorcontrib>Chkhartishvili, N</creatorcontrib><creatorcontrib>Matulionyte, R</creatorcontrib><creatorcontrib>Oprea, C</creatorcontrib><creatorcontrib>Kowalska, JD</creatorcontrib><creatorcontrib>Begovac, J</creatorcontrib><creatorcontrib>Miró, JM</creatorcontrib><creatorcontrib>Guaraldi, G</creatorcontrib><creatorcontrib>Paredes, R</creatorcontrib><creatorcontrib>Raben, D</creatorcontrib><creatorcontrib>Podlekareva, D</creatorcontrib><creatorcontrib>Peters, L</creatorcontrib><creatorcontrib>Lundgren, JD</creatorcontrib><creatorcontrib>Mocroft, A</creatorcontrib><title>The EuroSIDA study: 25 years of scientific achievements</title><title>HIV medicine</title><addtitle>HIV Med</addtitle><description>The EuroSIDA study was initiated in 1994 and follows adult people living with HIV (PLHIV) in 100 collaborating clinics across 35 countries covering all European regions, Israel and Argentina. The study aims to study the long‐term virological, immunological and clinical outcomes of PLHIV and to monitor temporal changes and regional differences in outcomes across Europe. Annually collected data include basic demographic characteristics, information on AIDS‐ and non‐AIDS‐related clinical events, and details about antiretroviral therapy (ART), hepatitis C treatment and other medications, in addition to a range of laboratory values. The summer 2016 data set held data from a total of 23 071 individuals contributing 174 481 person‐years of follow‐up, while EuroSIDA’s unique plasma repository held over 160 000 samples. Over the past 25 years, close to 300 articles have been published in peer‐reviewed journals (h‐index 52), covering a range of scientific focus areas, including monitoring of clinical and virological outcomes, ART uptake, efficacy and adverse events, the influence of hepatitis virus coinfection, variation in the quality of HIV care and management across settings and regions, and biomarker research. Recognizing that there remain unresolved issues in the clinical care and management of PLHIV in Europe, EuroSIDA was one of the cohorts to found The International Cohort Consortium of Infectious Disease (RESPOND) cohort consortium on infectious diseases in 2017. In celebration of the EuroSIDA study’s 25th anniversary, this article aims to summarize key scientific findings and outline current and future scientific focus areas.</description><subject>Acquired immune deficiency syndrome</subject><subject>AIDS</subject><subject>Antiretroviral agents</subject><subject>Antiretroviral therapy</subject><subject>Biomarkers</subject><subject>Cohort analysis</subject><subject>cohort studies</subject><subject>Consortia</subject><subject>Data collection</subject><subject>Demographics</subject><subject>Europe</subject><subject>Hepatitis</subject><subject>Hepatitis C</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Immunology</subject><subject>Infectious diseases</subject><subject>surveillance</subject><subject>Viruses</subject><issn>1464-2662</issn><issn>1468-1293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>D8T</sourceid><recordid>eNp10E1PwjAcBvDGaATRg1_ALPGih0nf13kjiEJC4kH02mzl31AEhiuD7NtbGXIwsZe-5Ncn7YPQNcEPJIzuzG0fCFUEn6A24VLFhKbsdL_mMZWSttCF93OMScJSfI5ajEieEJW0UTKZQTSoyuJt9NSL_Kaa1o8RFVENWemjwkbeOFhtnHUmyszMwRaWYe8v0ZnNFh6uDnMHvT8PJv1hPH59GfV749hwKnGcUFDWUMmxNNakRhEJSgqRJzQHPs0NZIKlIKbCihzLRBLGGFEiza21RHHWQXGT63ewrnK9Lt0yK2tdZE4fjj7DCjQPd5M0-LvGr8viqwK_0UvnDSwW2QqKymvKsBKUSIYDvf1D50VVrsJvguIkTZXELKj7Rpmy8L4Ee3wCwfqnfR3a1_v2g705JFb5EqZH-Vt3AN0G7NwC6v-T9HD00UR-Azqoi9c</recordid><startdate>202002</startdate><enddate>202002</enddate><creator>Laut, K</creator><creator>Kirk, O</creator><creator>Rockstroh, J</creator><creator>Phillips, A</creator><creator>Ledergerber, B</creator><creator>Gatell, J</creator><creator>Gazzard, B</creator><creator>Horban, A</creator><creator>Karpov, I</creator><creator>Losso, M</creator><creator>d’Arminio Monforte, A</creator><creator>Pedersen, C</creator><creator>Ristola, M</creator><creator>Reiss, P</creator><creator>Scherrer, AU</creator><creator>Wit, S</creator><creator>Aho, I</creator><creator>Rasmussen, LD</creator><creator>Svedhem, V</creator><creator>Wandeler, G</creator><creator>Pradier, C</creator><creator>Chkhartishvili, N</creator><creator>Matulionyte, R</creator><creator>Oprea, C</creator><creator>Kowalska, JD</creator><creator>Begovac, J</creator><creator>Miró, JM</creator><creator>Guaraldi, G</creator><creator>Paredes, R</creator><creator>Raben, D</creator><creator>Podlekareva, D</creator><creator>Peters, L</creator><creator>Lundgren, JD</creator><creator>Mocroft, A</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope><orcidid>https://orcid.org/0000-0003-1166-4462</orcidid><orcidid>https://orcid.org/0000-0002-5724-3914</orcidid><orcidid>https://orcid.org/0000-0001-7056-570X</orcidid><orcidid>https://orcid.org/0000-0003-2384-4807</orcidid><orcidid>https://orcid.org/0000-0003-0073-1789</orcidid><orcidid>https://orcid.org/0000-0001-8316-1122</orcidid></search><sort><creationdate>202002</creationdate><title>The EuroSIDA study: 25 years of scientific achievements</title><author>Laut, K ; Kirk, O ; Rockstroh, J ; Phillips, A ; Ledergerber, B ; Gatell, J ; Gazzard, B ; Horban, A ; Karpov, I ; Losso, M ; d’Arminio Monforte, A ; Pedersen, C ; Ristola, M ; Reiss, P ; Scherrer, AU ; Wit, S ; Aho, I ; Rasmussen, LD ; Svedhem, V ; Wandeler, G ; Pradier, C ; Chkhartishvili, N ; Matulionyte, R ; Oprea, C ; Kowalska, JD ; Begovac, J ; Miró, JM ; Guaraldi, G ; Paredes, R ; Raben, D ; Podlekareva, D ; Peters, L ; Lundgren, JD ; Mocroft, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4260-72e8fc26406cfc9c816e8655b72be4dbcea539e5d5f5b067613331859bfff1843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>AIDS</topic><topic>Antiretroviral agents</topic><topic>Antiretroviral therapy</topic><topic>Biomarkers</topic><topic>Cohort analysis</topic><topic>cohort studies</topic><topic>Consortia</topic><topic>Data collection</topic><topic>Demographics</topic><topic>Europe</topic><topic>Hepatitis</topic><topic>Hepatitis C</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Immunology</topic><topic>Infectious diseases</topic><topic>surveillance</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Laut, K</creatorcontrib><creatorcontrib>Kirk, O</creatorcontrib><creatorcontrib>Rockstroh, J</creatorcontrib><creatorcontrib>Phillips, A</creatorcontrib><creatorcontrib>Ledergerber, B</creatorcontrib><creatorcontrib>Gatell, J</creatorcontrib><creatorcontrib>Gazzard, B</creatorcontrib><creatorcontrib>Horban, A</creatorcontrib><creatorcontrib>Karpov, I</creatorcontrib><creatorcontrib>Losso, M</creatorcontrib><creatorcontrib>d’Arminio Monforte, A</creatorcontrib><creatorcontrib>Pedersen, C</creatorcontrib><creatorcontrib>Ristola, M</creatorcontrib><creatorcontrib>Reiss, P</creatorcontrib><creatorcontrib>Scherrer, AU</creatorcontrib><creatorcontrib>Wit, S</creatorcontrib><creatorcontrib>Aho, I</creatorcontrib><creatorcontrib>Rasmussen, LD</creatorcontrib><creatorcontrib>Svedhem, V</creatorcontrib><creatorcontrib>Wandeler, G</creatorcontrib><creatorcontrib>Pradier, C</creatorcontrib><creatorcontrib>Chkhartishvili, N</creatorcontrib><creatorcontrib>Matulionyte, R</creatorcontrib><creatorcontrib>Oprea, C</creatorcontrib><creatorcontrib>Kowalska, JD</creatorcontrib><creatorcontrib>Begovac, J</creatorcontrib><creatorcontrib>Miró, JM</creatorcontrib><creatorcontrib>Guaraldi, G</creatorcontrib><creatorcontrib>Paredes, R</creatorcontrib><creatorcontrib>Raben, D</creatorcontrib><creatorcontrib>Podlekareva, D</creatorcontrib><creatorcontrib>Peters, L</creatorcontrib><creatorcontrib>Lundgren, JD</creatorcontrib><creatorcontrib>Mocroft, A</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>HIV medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Laut, K</au><au>Kirk, O</au><au>Rockstroh, J</au><au>Phillips, A</au><au>Ledergerber, B</au><au>Gatell, J</au><au>Gazzard, B</au><au>Horban, A</au><au>Karpov, I</au><au>Losso, M</au><au>d’Arminio Monforte, A</au><au>Pedersen, C</au><au>Ristola, M</au><au>Reiss, P</au><au>Scherrer, AU</au><au>Wit, S</au><au>Aho, I</au><au>Rasmussen, LD</au><au>Svedhem, V</au><au>Wandeler, G</au><au>Pradier, C</au><au>Chkhartishvili, N</au><au>Matulionyte, R</au><au>Oprea, C</au><au>Kowalska, JD</au><au>Begovac, J</au><au>Miró, JM</au><au>Guaraldi, G</au><au>Paredes, R</au><au>Raben, D</au><au>Podlekareva, D</au><au>Peters, L</au><au>Lundgren, JD</au><au>Mocroft, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The EuroSIDA study: 25 years of scientific achievements</atitle><jtitle>HIV medicine</jtitle><addtitle>HIV Med</addtitle><date>2020-02</date><risdate>2020</risdate><volume>21</volume><issue>2</issue><spage>71</spage><epage>83</epage><pages>71-83</pages><issn>1464-2662</issn><eissn>1468-1293</eissn><abstract>The EuroSIDA study was initiated in 1994 and follows adult people living with HIV (PLHIV) in 100 collaborating clinics across 35 countries covering all European regions, Israel and Argentina. The study aims to study the long‐term virological, immunological and clinical outcomes of PLHIV and to monitor temporal changes and regional differences in outcomes across Europe. Annually collected data include basic demographic characteristics, information on AIDS‐ and non‐AIDS‐related clinical events, and details about antiretroviral therapy (ART), hepatitis C treatment and other medications, in addition to a range of laboratory values. The summer 2016 data set held data from a total of 23 071 individuals contributing 174 481 person‐years of follow‐up, while EuroSIDA’s unique plasma repository held over 160 000 samples. Over the past 25 years, close to 300 articles have been published in peer‐reviewed journals (h‐index 52), covering a range of scientific focus areas, including monitoring of clinical and virological outcomes, ART uptake, efficacy and adverse events, the influence of hepatitis virus coinfection, variation in the quality of HIV care and management across settings and regions, and biomarker research. Recognizing that there remain unresolved issues in the clinical care and management of PLHIV in Europe, EuroSIDA was one of the cohorts to found The International Cohort Consortium of Infectious Disease (RESPOND) cohort consortium on infectious diseases in 2017. In celebration of the EuroSIDA study’s 25th anniversary, this article aims to summarize key scientific findings and outline current and future scientific focus areas.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31647187</pmid><doi>10.1111/hiv.12810</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-1166-4462</orcidid><orcidid>https://orcid.org/0000-0002-5724-3914</orcidid><orcidid>https://orcid.org/0000-0001-7056-570X</orcidid><orcidid>https://orcid.org/0000-0003-2384-4807</orcidid><orcidid>https://orcid.org/0000-0003-0073-1789</orcidid><orcidid>https://orcid.org/0000-0001-8316-1122</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1464-2662 |
| ispartof | HIV medicine, 2020-02, Vol.21 (2), p.71-83 |
| issn | 1464-2662 1468-1293 |
| language | eng |
| recordid | cdi_swepub_primary_oai_swepub_ki_se_476179 |
| source | Wiley Online Library Journals Frontfile Complete; Wiley Online Library Free Content; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; SWEPUB Freely available online |
| subjects | Acquired immune deficiency syndrome AIDS Antiretroviral agents Antiretroviral therapy Biomarkers Cohort analysis cohort studies Consortia Data collection Demographics Europe Hepatitis Hepatitis C HIV Human immunodeficiency virus Immunology Infectious diseases surveillance Viruses |
| title | The EuroSIDA study: 25 years of scientific achievements |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T18%3A31%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20EuroSIDA%20study:%2025%20years%20of%20scientific%20achievements&rft.jtitle=HIV%20medicine&rft.au=Laut,%20K&rft.date=2020-02&rft.volume=21&rft.issue=2&rft.spage=71&rft.epage=83&rft.pages=71-83&rft.issn=1464-2662&rft.eissn=1468-1293&rft_id=info:doi/10.1111/hiv.12810&rft_dat=%3Cproquest_swepu%3E2341998603%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2341998603&rft_id=info:pmid/31647187&rfr_iscdi=true |